发明名称 INHIBITORS OF RGS PROTEINS
摘要 G-protein coupled receptors are a diverse group that are the target of over 50% of marketed drugs. Activation of these receptors results in the exchange of bound GDP for GTP in the Gα subunit of the heterotrimeric G-protein. The Gα subunit dissociates from the β/γ subunits and both proceed to affect downstream signaling targets. The signal terminates by the hydrolysis of GTP to GDP and is regulated by Regulators of G-protein Signaling (RGS) proteins that act as GTPase Activating Proteins (GAPs). This makes RGS proteins potentially desirable targets for “tuning” the effects of current therapies as well as developing novel pharmacotherapies. The present invention provides a convenient assay for identifying modulators of RGS proteins that can be adapted for high throughput screening utilizing the colorimetric dye, malachite green, to detect free phosphate in the presence of a test compound.
申请公布号 US2014303199(A1) 申请公布日期 2014.10.09
申请号 US201414245718 申请日期 2014.04.04
申请人 University of Iowa Research Foundation 发明人 Roman David
分类号 A61K31/56;A61K31/352;A61K31/4355 主分类号 A61K31/56
代理机构 代理人
主权项 1. A method of treating or preventing a disorder mediated by aberrant G protein signaling comprising administering to a patient in need thereof a therapeutically effective amount of a compound selected from the group consisting of formula UI-5, UI-1590, UI-1907 and UI-2034
地址 Iowa City IA US